Paul Adepoju
(He/Him)
As seen in:
CNN,
Business Insider,
Nature,
xXPainWarriorXx,
Yahoo News,
Yahoo Finance,
New Scientist,
Quartz,
Scientific American,
Biomed Central (BMC)
and
Covers:
Global health, science and medical research, including infectious diseases, vaccines, outbreak preparedness, biomedical innovation, health systems, access to medicines and health equity.
Science, Media, PhD | @ONA Award Winner | Byline: @Nature, @TheLancet, @NewScientist, @SciAm, @Devex, @SciDevNet
Get in touch with Paul
Contact Paul, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Paul Adepoju’s Biography
Read Full Bio →Paul Adepoju is a global health and science journalist covering biomedical research, infectious diseases, health systems, access to medicines, health financing and the politics of global health. His work has appeared in Devex, The Lancet, Nature, Scientific American, New Scientist, CNN, Health Policy Watch, BMJ and other international outlets.
A scientist-turned-journalist, Paul holds a PhD in Cell Biology and Genetics from the University of Ibadan. His reporting often examines how scientific b…
Paul Adepoju’s Journalist Portfolio
No Ebola vaccines exist for the strain in the current outbreak, but scientists are developing som...
